Albini A., Iwamoto Y., Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, et al. (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res47:3239-3245.
2.
Alvarez OA, Carmichael DF, DeClerck YA (1990). Inhibition of collagenolytic ability and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases . J Natl Cancer Inst82:589-595.
3.
Aoyagi M., Sasaki T., Ramamurthy NS, Golub LM (1996). Tetracycline/flurbiprofen combination therapy modulates bone remodeling in ovariectomized rats: preliminary observations . Bone19:629-635.
4.
Brown PB (1995). Matrix metalloproteinase inhibitors: a novel class of anticancer agents. Adv Enzyme Res35:293-301.
5.
Castonguay A., Rioux N. (1997). Inhibition of lung tumorigenesis by sulindac: comparison of two experimental protocols. Carcinogenesis18:491-496.
6.
Chambers AF, MacDonald IC, Schmidt EE, Koop S., Morris VL, Khokha R., et al. (1995). Steps in tumor metastasis: new concepts from intra vital video microscopy. Cancer Mets Rev14:279-301.
7.
Davies B.Brown PD, East N., Crimmin MJ, Balkwill FR (1993). A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res53:2087-2091.
8.
Dudak SD, Lopez A., Block NL, Lokeshwar BL (1996). Enhancement of radiation response of prostatic carcinoma by lonidamine. Anticancer Res16:3665-3672.
9.
Duke RCCohen JJ (1986). IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lvmphokine Res5:289-299.
10.
French DL, Ramos-DeSimone N., Rozinski K., Nuovo GJ (1994). Matrix metalloproteinase-9 in tumor cell invasion . Ann NY Acad Sci732:324-334.
11.
Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR (1991). Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med2:297-321.
12.
Hayward SW, Dahiya R., Cunha GR, Bartek J., Deshpande N., Narayan P. (1995). Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev Biol31 (A): 14-24.
13.
Hoosein NM, Boyd DD, Holla WJ, Mazar A., Henkin J., Chung Lwk (1991). Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma
14.
cell lines. Cancer Commun3:255-264.
15.
Isaacs JT, Isaacs WB, Feitz Wfj, Scheres J. (1986). Establishment and characterization of seven Dunning rat prostate cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. Prostate9:261-281.
16.
Kroon AM, Dontje Bhj, Holtrop M., Van den Bogert C. (1984). The mitochondrial genetic system as a target for chemotherapy: tetracycline as cytostatics. Cancer Lett25:33-40.
17.
Kumar S. (1995). ICE-like proteases in apoptosis. Trends Biochem Sci20:198-202.
18.
Lawrence JA, Steeg PS (1996). Mechanism of tumor invasion and metastasis. World J Urol14:124-130.
19.
Liotta LA, Stetler-Stevenson WG (1990). Metalloproteinase and cancer invasion. Sem Cancer Biol1:99-106.
20.
Liotta LA, Steeg PS, Stetler-Stevenson WG (1991). Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell64:327-336.
21.
Lokeshwar BL, Selzer MG, Block NL, Gunja-Smith Z. (1993). Secretion of matrix metalloproteinase and their inhibitors (TIMPs) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Cancer Res53:4493-4498.
22.
Lokeshwar BL, Selzer MG, Block NL, Golub LM (1996). Inhibition of tumor growth and metastasis by a non-antimicrobial tetracycline analogue in a prostate cancer model(abstract) . Proc Am Assoc Cancer Res38:2868.
23.
Melchiori A., Albini A., Ray JM, Stetler-Stevenson WG (1992). Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment . Cancer Res52:2353-2356.
24.
Mosmann T. (1983). Rapid calorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth65:55-63.
25.
Rao CV, Rivenson A., Simi B., Zang E., Kelloff G., Steele V., et al. (1995). Chemoprevention of colon carcinogenesis by sulindac: a non-steroidal anti-inflammatory agent. Cancer Res55:1464-1472.
26.
Sledge GW Jr, Qulali M., Goulet R., Bone EA, Fife R. ( 1995). Effect of metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Inst87:1546-1550.
27.
Stetler-Stevenson WG, Aznavoorian S., Liotta LA (1993). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Ann Rev Cell Biol9:541-573.
28.
van den Bogert C., Dontje Bhj, Holtrop M., Melis TE, Romijn JC, van Dongs JW, et al. (1986). Arrest of the proliferation of renal and prostate carcinomas of human origin by inhibition of mitochondrial protein synthesis. Cancer Res46:3283-3289.
